NextRNA Therapeutics is based in Boston. It has raised $56M in total funding. Latest round: Series A.
NextRNA Therapeutics is based in Boston. NextRNA Therapeutics has raised $56M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in August 2022. The round record for NextRNA Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Cobro Ventures, Lightchain Capital, Circle Alternative Investments, Evans Capital Management, Jefferies LLC, Rivas Capital and 2 others. 8 distinct backers are named across the disclosed rounds.
Totals shown for NextRNA Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Boston and the investors behind them below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026